126 related articles for article (PubMed ID: 10895993)
1. Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
Maassen VanDenBrink A; Reekers M; Bax WA; Saxena PR
Pharmacol Toxicol; 2000 Jun; 86(6):287-90. PubMed ID: 10895993
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
3. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
[TBL] [Abstract][Full Text] [Related]
4. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
6. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
[TBL] [Abstract][Full Text] [Related]
7. Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
van den Broek RW; MaassenVanDenBrink A; Mulder PG; Bogers AJ; Avezaat CJ; John GW; Saxena PR
Eur J Pharmacol; 2002 May; 443(1-3):125-32. PubMed ID: 12044802
[TBL] [Abstract][Full Text] [Related]
8. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
9. Characterization of binding, functional activity, and contractile responses of the selective 5-HT
Rubio-Beltrán E; Labastida-Ramírez A; Haanes KA; van den Bogaerdt A; Bogers AJJC; Zanelli E; Meeus L; Danser AHJ; Gralinski MR; Senese PB; Johnson KW; Kovalchin J; Villalón CM; MaassenVanDenBrink A
Br J Pharmacol; 2019 Dec; 176(24):4681-4695. PubMed ID: 31418454
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Jähnichen S; Radtke OA; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.
van den Broek RW; MaassenVanDenBrink A; de Vries R; Bogers AJ; Stegmann AP; Avezaat CJ; Saxena PR
Eur J Pharmacol; 2000 Oct; 407(1-2):165-73. PubMed ID: 11050304
[TBL] [Abstract][Full Text] [Related]
12. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
Choppin A; O'Connor SE
Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730
[TBL] [Abstract][Full Text] [Related]
13. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
[TBL] [Abstract][Full Text] [Related]
14. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I; Case B; Olivier A; Hamel E
Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
[TBL] [Abstract][Full Text] [Related]
15. 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.
Morecroft I; Heeley RP; Prentice HM; Kirk A; MacLean MR
Br J Pharmacol; 1999 Oct; 128(3):730-4. PubMed ID: 10516655
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
[TBL] [Abstract][Full Text] [Related]
17. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
[TBL] [Abstract][Full Text] [Related]
19. Cranioselectivity of sumatriptan revisited: pronounced contractions to sumatriptan in small human isolated coronary artery.
Chan KY; Labruijere S; Ramírez Rosas MB; de Vries R; Garrelds IM; Danser AH; Villalón CM; van den Bogaerdt A; Dirven C; MaassenVanDenBrink A
CNS Drugs; 2014 Mar; 28(3):273-8. PubMed ID: 24430784
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
